Digital Tool to Improve Maternal Mental Health: Supporting Well-being and Early Detection During Pregnancy and Postpartum

What this Trial Is About

Researchers are evaluating a digital health tool called Dana app designed to improve maternal well-being and support mental health monitoring during the perinatal period. This study focuses on women transitioning into motherhood, aiming to enhance early detection of mental health disorders, assist healthcare professionals in diagnosis and monitoring, and improve obstetric outcomes as well as infant psychological and cognitive development. The trial addresses the high prevalence of mood disorders in pregnant women and the challenges of underdiagnosis and inadequate treatment that affect both mother and child. Participants will use the Dana mobile application from 12-14 weeks of pregnancy until 24 months after giving birth. The app includes biopsychosocial programs based on cognitive-behavioral strategies such as psychoeducation, mindfulness, and relaxation exercises. It offers a community forum, a mood diary, and built-in mental health screening questionnaires. Participants who own wearables can connect them to monitor sleep, activity, and stress. The study compares an intervention group using the full app to a control group with an app containing no content. During the study, women will undergo regular assessments of their emotional state, lifestyle, clinical, and obstetric data at multiple time points including 12-14 and 33-34 weeks of pregnancy, and 6 weeks, 6, 12, and 24 months postpartum. Infant development will also be evaluated up to two years old. Data protection is ensured through pseudonymization. Researchers will measure maternal well-being, early detection of mental health issues, diagnostic support, obstetric and neonatal outcomes, and infant neurodevelopment. The total participation lasts from early pregnancy to two years postpartum.

MamaConecta: Digital Tool for Maternal Mental Health